Press Release

Radiopharmaceuticals Market Share, Size, Competitive Landscape, Trends, Analysis And Global Forecast To 2026

Radiopharmaceuticals Market by Top Key Players are Lantheus Medical Imaging, Inc., Cardinal Health, Norgine B.V., Curium, Advanced Accelerator Applications (Novartis AG), Bracco Diagnostic Inc., Jubilant Life Sciences Limited, GE Healthcare (General Electric Company)

Radiopharmaceuticals MarketThe global radiopharmaceuticals market size is projected to reach USD 9.54 billion by 2026. According to a report published by Fortune Business Insights, titled “Radiopharmaceuticals Market Size, Share & Industry Analysis, By Type (PET Radiopharmaceuticals, SPECT Radiopharmaceuticals), By Application (Neurology, Cardiology, Oncology, and Others), By End User (Hospitals & Clinics, Diagnostic Centres, and Others) and Regional Forecast, 2019-2026,” the market was valued at USD 4.86 billion in 2018. Driven by increasing number of successful clinical trials, the market will exhibit a CAGR of 9.0% from 2019-2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/nuclear-medicine-radiopharmaceuticals-market-101812

Radiopharmaceuticals are substances that are used to diagnose specific medical problems or diseases. Increasing imaging capabilities and efficiencies have led to a wide product adoption across the world. Increasing number of successful clinical trials associated with radiopharmaceuticals will fuel the demand for the product. Recent drug application area discoveries have showcased promise for the companies operating in the market. Technological advancements in nuclear imaging and their applications in diagnosis of cancer and other serious diseases have opened up a huge potential for growth.

A few of the leading companies that are operating in the global radiopharmaceuticals market are:

  • Lantheus Medical Imaging, Inc.
  • Cardinal Health
  • Norgine B.V.
  • Curium
  • Advanced Accelerator Applications (Novartis AG)
  • Bracco Diagnostic Inc.
  • Jubilant Life Sciences Limited
  • GE Healthcare (General Electric Company)

Request a Sample Copy of Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nuclear-medicine-radiopharmaceuticals-market-101812

Driven by Increasing Number of Product Launches, Market to Expand at a High Rate

The increasing number of product launches has offered a wider scope for growth. The presence of several pipeline drugs will open up a potential for the growth of the market in the coming years. The increased investment has massively helped the development of these pipeline drugs. Increased emphasis on R&D of pipeline drugs has enabled the possibilities to explore the untapped potential that is carried by radiopharmaceuticals. In 2018, Norgine B.V. announced the launch of Lymphoseek, a radiopharmaceutical designed for oncological procedures. The report highlights new products, similar to Lymphoseek and gauges the impact of these products on the market.

North America to Witness Highest Growth; Growing Adoption of Nuclear Imaging to Aid Growth

The report segments the market on the basis of regional demographics into Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, North America will emerge dominant in the coming years. The advancements in nuclear imaging has contributed to the growth of the market in North America. Increased awareness regarding the adverse effects of cancer and other serious diseases will create several growth opportunities for the companies operating in the regional market of North America.

More Trending Topics from Fortune Business Insights:

Microbiome Therapeutics Market 2020 | Global Industry Analysis, Potential Growth, Key Players, Latest Trends Forecasts till 2026

Mobile Cardiac Telemetry Systems Market Analysis, Share, Trends, Competitive Landscape, Developments, Forecast by 2026

Spirometers Market 2020: Global Industry Analysis by Top Manufacturers with Size, Share, Segments, Drivers and Challenges

Tags

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close